SCHEMBL25820671

SCHEMBL25820671

O=C(Nc1cc(Nc2ccccc2)ccc1F)c1cccc(Nc2ccnc3ccc(F)cc23)c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DNMT1 P26358 6/20 0.63
DNMT3A Q9Y6K1 5/20 0.63
CCNC P24863 1/20 0.52
CDK8 P49336 1/20 0.52
DNMT3L Q9UJW3 3/20 0.50
EHMT1 Q9H9B1 2/20 0.50
KMT2A Q03164 2/20 0.50
MEN1 O00255 1/20 0.50
NPC1 O15118 1/20 0.50
RAB9A P51151 1/20 0.50
AURKA O14965 2/20 0.48
AURKB Q96GD4 2/20 0.48
TGFBR1 P36897 1/20 0.48
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
MAPK14 Q16539 3/20 0.46
MAPKAPK2 P49137 1/20 0.45
KDR P35968 1/20 0.44
USP2 O75604 1/20 0.44
MAPT P10636 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30290933 0.94 DNMT1 (0.58) DNMT1DNMT3ACCNCCDK8DNMT3L
SCHEMBL24010240 0.94 DNMT1 (0.58) DNMT1DNMT3ACCNCCDK8DNMT3L
SCHEMBL25820675 0.94 DNMT1 (0.66) DNMT1DNMT3ACCNCCDK8DNMT3L
SCHEMBL24005986 0.92 DNMT1 (0.74) DNMT1DNMT3ACCNCCDK8DNMT3L
SCHEMBL25820646 0.91 DNMT1 (0.61) DNMT1DNMT3ACCNCCDK8DNMT3L
SCHEMBL25820533 0.90 DNMT1 (0.68) DNMT1DNMT3ACCNCCDK8DNMT3L
SCHEMBL24011122 0.90 DNMT1 (0.68) DNMT1DNMT3ACCNCCDK8DNMT3L
SCHEMBL30290755 0.90 DNMT1 (0.68) DNMT1DNMT3ACCNCCDK8DNMT3L
SCHEMBL24010920 0.89 DNMT1 (0.61) DNMT1DNMT3ACCNCCDK8DNMT3L
SCHEMBL30290771 0.89 DNMT1 (0.61) DNMT1DNMT3ACCNCCDK8DNMT3L

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230219927-A1 AKT3 MODULATORS Georgiamune Inc. 2023-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230219927-A1 AKT3 MODULATORS AKT3, AKT2, PIK3CA DNMT1 4335/4885DNMT3A 4603/4885CCNC 491/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.